Cyclin-Dependent Kinase Inhibitor 3 (CDKN3) (N-Term) Peptide
Quick Overview for Cyclin-Dependent Kinase Inhibitor 3 (CDKN3) (N-Term) Peptide (ABIN974788)
Target
Origin
Source
Application
-
-
Protein Region
- N-Term
-
Sequence
- LKSYGIQDVF VFCTRGELSK YRVPNLLDLY QQYGIVTHHH PIPDGGTPDI
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-Cdkn3 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- CDKN3 (Cyclin-Dependent Kinase Inhibitor 3 (CDKN3))
-
Background
-
Cdkn3 may play a role in cell cycle regulation. It has dual specificity phosphatase active toward substrates containing either phosphotyrosine or phosphoserine residues. It dephosphorylates CDK2 at 'Thr-160' in a cyclin-dependent manner.
Alias Symbols: 2410006H10Rik
Protein Size: 211 -
Molecular Weight
- 23 kDa
-
Gene ID
- 72391
-
NCBI Accession
- NM_028222, NP_082498
-
UniProt
- Q810P3
Target
-